Decitabine 50 mg/20mL (Decitabine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 50 mg/20mL

Decitabine 50 mg/20mL is a lyophilized powder for solution, used for intravenous administration. This medication is commonly associated with certain types of cancer treatments. Learn more about its uses and effects.

Strength

50 mg/20mL

Pack Size

1 VIAL in 1 CARTON (25021-219-20) / 20 mL in 1 VIAL

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Decitabine is primarily used in the treatment of specific types of cancer. It works by affecting the growth of cancer cells, making it a key component in certain chemotherapy regimens. Patients often wonder, 'What is Decitabine used for?' and the answer typically involves its role in managing myeloid leukemia and other related conditions.

Side Effects

Common effects of Decitabine may include fatigue, nausea, and low blood cell counts. These effects can vary from person to person and are generally managed under medical supervision. It's important to discuss any concerns with a healthcare provider.

Precautions & Warnings

Decitabine should be handled with care, as it is a potent medication. It is crucial to follow proper storage and administration guidelines to ensure safety. Always consult a healthcare professional for specific precautions related to your treatment.

Avoid Interactions

Decitabine may interact with other medications, including those that affect the immune system or blood cell production. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Decitabine is primarily used in the treatment of certain types of cancer, particularly myeloid leukemia.

Decitabine is administered intravenously after being reconstituted from its lyophilized powder form.

Common side effects may include fatigue, nausea, and low blood cell counts.

Decitabine may interact with other medications, so it's important to consult a healthcare provider before combining treatments.

Decitabine should be stored according to the manufacturer's guidelines to maintain its efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.